Skip to main content

Table 1 Demographic characteristics and antibody profile of APS and SNAPS patients

From: “Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort

 APSSNAPSSLESSRAASHC
Numbers19290103293130120
Age (Q1–Q3)35 (30–46)39 (32–51)34 (29–43)42 (35–51)47 (40–58)34.5 (27–40)39 (34–46)
Sex (F/M)162/3077/1392/827/228/315/15108/12
Arterial thrombosis74 (39%)53 (59%)0 (0%)0 (0%)0 (0%)0 (0%)0 (0%)
Venous thrombosis78 (41%)33 (37%)0 (0%)0 (0%)0 (0%)0 (0%)0 (0%)
Early fetal loss36 (22%)12 (16%)0 (0%)0 (0%)0 (0%)0 (0%)0 (0%)
Late fetal loss81 (50%)18 (23%)0 (0%)0 (0%)0 (0%)0 (0%)0 (0%)
aCL IgG/IgM(+)115 (60%)0 (0%)6 (6%)0 (0%)0 (0%)0 (0%)0 (0%)
aB2GPI IgG/IgM(+)130 (68%)0 (0%)13 (13%)0 (0%)0 (0%)1 (3%)0 (0%)
LA(+)133 (69%)0 (0%)6 (6%)0 (0%)0 (0%)0 (0%)0 (0%)
aCL IgA(+)80 (42%)11 (12%)12 (12%)0 (0%)0 (0%)0 (0%)0 (0%)
aB2GPI IgA(+)75 (39%)9 (10%)7 (7%)0 (0%)0 (0%)0 (0%)0 (0%)
aPS/PT IgG(+)137 (71%)32 (36%)15 (15%)1 (3%)0 (0%)0 (0%)0 (0%)
aPS/PT IgM(+)141 (73%)32 (36%)33 (32%)7 (24%)0 (0%)3 (10%)5 (4%)
aB2GPI D1 IgG(+)119 (62%)14 (16%)7 (7%)0 (0%)0 (0%)0 (0%)2 (2%)